Anima Biotech’s machine learning programme ‘reveals new mRNA drug targets’
The company employs machine learning to uncover disease mechanisms at the mRNA level and to identify therapeutic candidates.
The company employs machine learning to uncover disease mechanisms at the mRNA level and to identify therapeutic candidates.
What's Your Reaction?
